CD8A and neoplasm: Mastria et al. proved that chimeric polypeptide DOX (a nanoparticle DOX preparation) significantly enhanced anti-cancer immunity by stimulating CD8+ T cells and limiting tumor growth, metastasis, and spread (Mastria et al., 2018).